{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-043666","form_type":"8-K","ticker":"PAVM","cik":"0001624326","company_name":"PAVmed Inc.","filed_at":"2023-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.824838+00:00","generated_at":"2026-06-07T18:04:26.314006+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"PAVmed 1-for-15 reverse split Dec 7; declares Lucid dividend of ~3.3M shares","bullets":["Reverse split at 1-for-15 effective Dec 7, 2023; authorized common reduced from 250M to 50M shares.","Dividend of ~3.3M Lucid Diagnostics (LUCD) shares to PAVmed holders of record Jan 15, 2024; distribution within 30 days.","Series Z warrants maturity extended by 12 months to April 30, 2025; exercise price and shares adjusted proportionately.","Reverse split aims to regain Nasdaq minimum $1 bid price compliance; company had until Dec 26, 2023.","Accredited investor holding convertible notes waived as-converted participation in Lucid dividend."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-043666","json":"https://secwatch.observer/filing/0001493152-23-043666.json","markdown":"https://secwatch.observer/filing/0001493152-23-043666.md","text":"https://secwatch.observer/filing/0001493152-23-043666.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1624326/000149315223043666/0001493152-23-043666-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1624326/000149315223043666/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T18:04:26.314006+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9fb17c04954caa0d016ec0a0bce168443706c9c7","claim":"PAVmed Inc.: Filing of a Certificate of Amendment to the Amended and Restated Certificate of Incorporation to effect a 1-for-15 reverse stock split, reducing the authorized common shares from 250,000,000 to 50,000,000 (effective 2023-12-07).","evidence_excerpt":"On December 5, 2023, the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the “ Charter Amendment ”) with the Secretary of State of the State of Delaware, pursuant to which, effective at 12:01 a.m. Eastern Time on December 7, 2023, the Reverse Split will be effected.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1624326/000149315223043666/0001493152-23-043666-index.htm","confidence":0.95,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-12-07"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}